Advances in mesenchymal stem cell-mediated gene therapy for cancer
|Title:||Advances in mesenchymal stem cell-mediated gene therapy for cancer||Authors:||Dwyer, Roisin M.
Barry, Frank P.
|Permanent link:||http://hdl.handle.net/10197/5001||Date:||2010||Abstract:||Mesenchymal stem cells have a natural tropism for tumours and their metastases, and are also considered immunoprivileged. This remarkable combination of properties has formed the basis for many studies investigating their potential as tumour-specific delivery vehicles for suicide genes, oncolytic viruses and secreted therapeutic proteins. The aim of the present review is to discuss the range of approaches that have been used to exploit the tumour-homing capacity of mesenchymal stem cells for gene delivery, and to highlight advances required to realize the full potential of this promising approach.||Type of material:||Journal Article||Publisher:||Springer (Biomed Central Ltd.)||Copyright (published version):||2010 Springer (Biomed Central Ltd.)||Keywords:||mesenchymal stem cells (MSCs); targeted gene delivery; gene therapy; cancer||DOI:||10.1186/scrt25||Language:||en||Status of Item:||Peer reviewed|
|Appears in Collections:||Conway Institute Research Collection|
SBI Research Collection
Show full item record
Page view(s) 5048
This item is available under the Attribution-NonCommercial-NoDerivs 3.0 Ireland. No item may be reproduced for commercial purposes. For other possible restrictions on use please refer to the publisher's URL where this is made available, or to notes contained in the item itself. Other terms may apply.